首页> 外国专利> NOVEL LACTOBACILLUS, THE PREPARATION OF LACTOBACILLUS, ACTIVATING LIVING ORGANISMS, AND PHYLACTIC OR THERAPEUTIC AGENT FOR TREATMENT OF INFECTION OF LIVING ORGANISMS

NOVEL LACTOBACILLUS, THE PREPARATION OF LACTOBACILLUS, ACTIVATING LIVING ORGANISMS, AND PHYLACTIC OR THERAPEUTIC AGENT FOR TREATMENT OF INFECTION OF LIVING ORGANISMS

机译:新型乳酸菌,乳酸菌的制备,活性生物以及用于治疗生物感染的物理或治疗剂

摘要

The invention relates to the strainFERM BP-10059 (FERM P-19443), which can be applied as Probiotic and which can form colonies and proliferate in centres of infection, eliminating pathogenic bacteria, and to the prophylactic and therapeutic agent, which contains the mentioned strain. The mentioned strain has such main properties:(1) can be cultivated in the presence of 1-4 amino acids as carbon source, essential for growth; (2)when cultural medium, stimulating growth, is inoculated with this strain andin identical quantity and subjected to anaerobic mixed cultivation at 37 °, the final quantity of lactobacillus is 50 % or more from the quantity of coli forms;(3) after cultivation in corresponding cultural medium the final pH value is 4.0 or lower, and the highest acidity of 1.5 % or more;(4) this strain is resistant to 5 % of salts of bile acids;(5) this strain produces antibiotic.
机译:本发明涉及可作为益生菌使用并能在感染中心形成菌落并增殖,消除病原细菌的FERM BP-10059(FERM P-19443)菌株,以及涉及上述的预防和治疗剂。应变。所述菌株具有以下主要特性:(1)可以在1-4个氨基酸作为碳源存在下培养,这对于生长是必不可少的; (2)当该菌株接种刺激生长的培养基并等量接种,并在37°下进行厌氧混合培养时,乳酸杆菌的最终量为大肠菌形式的50%或更多;(3)培养后在相应的培养基中,最终pH值为4.0或更低,最高酸度为1.5%或更高;(4)该菌株对5%的胆汁酸盐具有抗性;(5)该菌株产生抗生素。

著录项

  • 公开/公告号UA88271C2

    专利类型

  • 公开/公告日2009-10-12

    原文格式PDF

  • 申请/专利权人 BHPH COMPANY LIMITED;

    申请/专利号UAA200602009

  • 申请日2004-07-27

  • 分类号C12N1/20;A01N63;A01N63/02;A01P3;A61K31/19;A61K31/192;A61K31/235;A61K31/375;A61K33/26;A61K35/74;A61K35/747;A61P1/02;A61P31/04;A61P43;C12R1/245;

  • 国家 UA

  • 入库时间 2022-08-21 19:25:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号